As CVS Health's new CEO David Joyner steps into the top job, Wall Street analysts and some investors are questioning whether ...

That experience was in the back of my mind when reading about the struggles at CVS Health, which owns Aetna, and the ouster ...

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in ...

CVS Health CEO Karen Lynch is stepping down after nearly four years at the helm, as the healthcare conglomerate faces ...

During her time at the helm of CVS Health, former chief executive Karen Lynch often placed her complicated family history at ...

CVS Health has replaced Karen Lynch with David Joyner as CEO, part of an attempt to turn the struggling company around.

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $82.00. The ...

In a report released today, David S Macdonald from Truist Financial maintained a Buy rating on CVS Health (CVS – Research Report). The ...

In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

CVS Health CEO and president Karen Lynch has stepped down and will be replaced by David Joyner effective Oct. 17. Here are 10 things to know: ...

Walgreens also has over $20 billion of long-term leases, primarily stores. Although these don’t have to be funded in the same way as borrowings in a buyout, they are another call on its cashflow. At ...